SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001062993-12-001837
Filing Date
2012-05-16
Accepted
2012-05-16 17:19:47
Documents
6
Period of Report
2012-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 6-K form6k.htm 6-K 3676
2 INTERIM FINANCIAL STATEMENTS MARCH 31, 2012 exhibit99-1.htm EX-99.1 641522
3 MANAGEMENT DISCUSSION AND ANALYSIS exhibit99-2.htm EX-99.2 109906
4 CERTIFICATION OF INTERIM FILING - CEO exhibit99-3.htm EX-99.3 7507
5 CERTIFICATION OF INTERIM FILING - CFO exhibit99-4.htm EX-99.4 6548
6 GRAPHIC merusx1x1.jpg GRAPHIC 4444
  Complete submission text file 0001062993-12-001837.txt   776650
Mailing Address 1177 WEST HASTINGS STREET, SUITE 2007 VANCOUVER A1 V6E 2K3
Business Address 1177 WEST HASTINGS STREET, SUITE 2007 VANCOUVER A1 V6E 2K3 604-805-7783
Merus Labs International Inc. (Filer) CIK: 0001031516 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0930
Type: 6-K | Act: 34 | File No.: 000-30082 | Film No.: 12849628
SIC: 2834 Pharmaceutical Preparations